, 2011). There exists now no comprehensive Evaluation in the efficacy and basic safety of avatrombopag in patients with thrombocytopenia. Within this review, a pc-based search was accustomed to retrieve randomized, double-blind scientific trials involving people with thrombocytopenia as well as relevant data had been extracted to permit an evidence